Published in Brain on October 01, 1990
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Hum Mol Genet (2011) 2.34
Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry (1995) 1.64
Selective defect of in vivo glycolysis in early Huntington's disease striatum. Proc Natl Acad Sci U S A (2007) 1.57
Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD. PLoS One (2015) 1.40
Mitochondrial structural and functional dynamics in Huntington's disease. Brain Res Rev (2009) 1.37
Brain imaging and cognitive dysfunctions in Huntington's disease. J Psychiatry Neurosci (2006) 1.35
Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. Proc Natl Acad Sci U S A (2002) 1.29
Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease. Biochim Biophys Acta (2011) 1.16
Evidence of thalamic disinhibition in patients with hemichorea: semiquantitative analysis using SPECT. J Neurol Neurosurg Psychiatry (2002) 1.13
The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol (1993) 1.13
Functional imaging in Huntington's disease. Exp Neurol (2009) 1.08
Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease. Brain Res Bull (2009) 1.07
Non-ketotic hyperglycaemic chorea: a SPECT study. J Neurol Neurosurg Psychiatry (1996) 1.05
PET/CT in diagnosis of movement disorders. Ann N Y Acad Sci (2011) 1.05
Functional imaging of cerebral blood flow and glucose metabolism in Parkinson's disease and Huntington's disease. Mol Imaging Biol (2007) 1.03
Role of cerebral cortex in the neuropathology of Huntington's disease. Front Neural Circuits (2013) 1.02
Brain networks in Huntington disease. J Clin Invest (2011) 1.02
Cortical and striatal neurone number in Huntington's disease. Acta Neuropathol (1994) 1.00
Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease. NeuroRx (2004) 0.96
Reduced regional cerebral blood flow in Huntington's disease studied by SPECT. J Neurol Neurosurg Psychiatry (1992) 0.93
Meclizine is neuroprotective in models of Huntington's disease. Hum Mol Genet (2010) 0.92
Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease. Biochim Biophys Acta (2010) 0.91
Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study. J Neurol Neurosurg Psychiatry (1997) 0.89
Mitochondrial matters of the brain: the role in Huntington's disease. J Bioenerg Biomembr (2010) 0.87
Early deficits in glycolysis are specific to striatal neurons from a rat model of huntington disease. PLoS One (2013) 0.84
Decreased Metabolism in the Cerebral Cortex in Early-Stage Huntington's Disease: A Possible Biomarker of Disease Progression? J Clin Neurol (2013) 0.84
A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington's disease in mice. Nat Commun (2013) 0.83
QEEG Measures in Huntington's Disease: A Pilot Study. PLoS Curr (2010) 0.78
Positron emission tomography imaging of transplant function. NeuroRx (2004) 0.78
Glucose transporter 3 is a rab11-dependent trafficking cargo and its transport to the cell surface is reduced in neurons of CAG140 Huntington's disease mice. Acta Neuropathol Commun (2014) 0.78
Current status of PET imaging in Huntington's disease. Eur J Nucl Med Mol Imaging (2016) 0.78
Neuroimaging in Huntington's disease. World J Radiol (2014) 0.78
The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease. Mech Ageing Dev (2016) 0.77
Transplantation of induced pluripotent stem cells improves functional recovery in Huntington's disease rat model. PLoS One (2014) 0.77
Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism. Eur J Nucl Med Mol Imaging (2010) 0.77
The design of clinical trials for cell transplantation into the central nervous system. NeuroRx (2004) 0.77
Striatal hypometabolism in premanifest and manifest Huntington's disease patients. Eur J Nucl Med Mol Imaging (2016) 0.77
HdhQ111 Mice Exhibit Tissue Specific Metabolite Profiles that Include Striatal Lipid Accumulation. PLoS One (2015) 0.76
Enhanced neuronal glucose transporter expression reveals metabolic choice in a HD Drosophila model. PLoS One (2015) 0.75
Benzodiazepine receptor quantification in Huntington's disease with [(123)I]omazenil and SPECT. J Neurol Neurosurg Psychiatry (2001) 0.75
Molecular Imaging Markers to Track Huntington's Disease Pathology. Front Neurol (2017) 0.75
PET Imaging in Huntington's Disease. J Huntingtons Dis (2015) 0.75
Huntington's disease and mitochondrial alterations: emphasis on experimental models. J Bioenerg Biomembr (2010) 0.75
A neural basis for general intelligence. Science (2000) 4.49
XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev (1998) 2.58
Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med (2001) 2.18
Brain and brain tumor uptake of L-3-[123I]iodo-alpha-methyl tyrosine: competition with natural L-amino acids. J Nucl Med (1991) 2.07
Beta-oxidation of 1-[14C]-17-[131I]-iodo-heptadecanoic acid following intracoronary injection in humans results in similar release of both tracers. Eur J Nucl Med (1993) 1.95
Role of the premotor cortex in recovery from middle cerebral artery infarction. Arch Neurol (1998) 1.94
Functional anatomy of intrinsic alertness: evidence for a fronto-parietal-thalamic-brainstem network in the right hemisphere. Neuropsychologia (1999) 1.76
Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease. J Neurol (1993) 1.71
Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur J Neurosci (1999) 1.66
Y-receptor subtypes--how many more? Trends Neurosci (1997) 1.55
Fully-3D PET image reconstruction using scanner-independent, adaptive projection data and highly rotation-symmetric voxel assemblies. IEEE Trans Med Imaging (2011) 1.54
The comparison of 2-18F-2-deoxyglucose and 15-(ortho-123I-phenyl)-pentadecanoic acid uptake in persisting defects on thallium-201 tomography in myocardial infarction. J Nucl Med (1991) 1.51
Radiation hormesis. Its emerging significance in medical practice. Invest Radiol (1993) 1.43
Noninvasive assessment of regional cardiac adenosine using positron emission tomography. J Nucl Med (1992) 1.41
Radiosensitivity of the colony-forming cells of the mouse bone marrow. Proc Soc Exp Biol Med (1970) 1.38
The neural circuitry involved in the reading of German words and pseudowords: A PET study. J Cogn Neurosci (1999) 1.35
The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med (1993) 1.35
Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand (1992) 1.29
Iodine-125, a tracer in cell biology: physical properties and biological aspects. Phys Med Biol (1970) 1.28
History of tuberculosis. Respiration (1998) 1.24
Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med (1999) 1.21
Value of transesophageal echocardiography as an adjunct to transthoracic echocardiography in evaluation of native and prosthetic valve endocarditis. Chest (1991) 1.20
O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging (2005) 1.20
Expectation maximization reconstruction of positron emission tomography images using anatomical magnetic resonance information. IEEE Trans Med Imaging (1997) 1.20
Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization. Neuroscience (2002) 1.18
[New theoretical values in exploration of the respiratory function of the lung]. Bull Physiopathol Respir (Nancy) (1972) 1.17
Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity. Diabetologia (2006) 1.16
Distribution and utilization of 15N in cowpeas injected into the stem under influence of water deficit. Isotopes Environ Health Stud (2000) 1.16
The role of diaschisis in stroke recovery. Stroke (1999) 1.14
[Infection experiments with the cotton rat filaria Litomosoides carinii in Mastomys natalensis (Smith, 1834)]. Z Parasitenkd (1968) 1.13
Episodic retrieval activates the precuneus irrespective of the imagery content of word pair associates. A PET study. Brain (1999) 1.12
Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J Immunol (1996) 1.12
Incidence of asymptomatic extracranial arterial disease. Stroke (1982) 1.11
Performance characteristics of an eight-ring whole body PET scanner. J Comput Assist Tomogr (1990) 1.10
Velocity modulation and rhythmic synchronization of gait in Huntington's disease. Mov Disord (1999) 1.09
Candidaemia and bacterial infections in patients with lung disease. Lancet (1976) 1.09
Animal research. Reliability of protocol reviews for animal research. Science (2001) 1.08
[In-vivo-examinations of the relative radiosensitivity of hypoxic tumor cells (author's transl)]. Strahlentherapie (1977) 1.08
A neural correlate of syntactic encoding during speech production. Proc Natl Acad Sci U S A (2001) 1.07
Biologic responses to low doses of ionizing radiation: Detriment versus hormesis. Part 2. Dose responses of organisms. J Nucl Med (2001) 1.07
Surgical treatment of 50 carotid dissections: indications and results. J Vasc Surg (2000) 1.07
A human ubiquitin-conjugating enzyme homologous to yeast UBC8. J Biol Chem (1994) 1.07
Inactivation of mammalian cells after disintegration of 3H or 125I in cell DNA at -196 degrees C. Int J Radiat Biol Relat Stud Phys Chem Med (1973) 1.06
Neural correlates of religious experience. Eur J Neurosci (2001) 1.05
Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II study. Strahlenther Onkol (2012) 1.05
The selenium state of children. II. Selenium content of serum, whole blood, hair and the activity of erythrocyte glutathione peroxidase in dietetically treated patients with phenylketonuria and maple-syrup-urine disease. Eur J Pediatr (1978) 1.04
Changed pattern of regional glucose metabolism during yoga meditative relaxation. Neuropsychobiology (1991) 1.04
Letter: Absorption of zinc in acrodermatitis enteropathica. Lancet (1975) 1.04
Physiological thymidine reutilization in rat bone marrow. Proc Soc Exp Biol Med (1966) 1.03
PET imaging with yttrium-86: comparison of phantom measurements acquired with different PET scanners before and after applying background subtraction. Eur J Nucl Med Mol Imaging (2003) 1.03
Intracellular stimulation of biochemical control mechanisms by low-dose, low-LET irradiation. Health Phys (1987) 1.02
Kinetics of histone methylation in vivo and its relation to the cell cycle in Ehrlich ascites tumor cells. Eur J Biochem (1975) 1.02
Detection of early atherosclerotic lesions by duplex scanning of the carotid artery. J Clin Ultrasound (1984) 1.02
GPR56, a novel secretin-like human G-protein-coupled receptor gene. Genomics (1999) 1.01
The effect of MR surface coils on PET quantification in whole-body PET/MR: results from a pseudo-PET/MR phantom study. Med Phys (2011) 1.01
Trace element concentration in human brain. Activation analysis of cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium. Brain (1975) 1.01
Impaired thrombin generation in beta 2-glycoprotein I null mice. J Biol Chem (2001) 1.00
An alternative to absorbed dose, quality, and RBE at low exposures. Radiat Res Suppl (1985) 0.99
Impairment of rapid movement in Huntington's disease. Brain (1987) 0.99
Cell-oriented alternatives to dose, quality factor, and dose equivalent for low-level radiation. Health Phys (1990) 0.98
A novel neuropeptide Y analog, N-acetyl [Leu28,Leu31]neuropeptide Y-(24-36), with functional specificity for the presynaptic (Y2) receptor. Eur J Pharmacol (1994) 0.98
The design of an animal PET: flexible geometry for achieving optimal spatial resolution or high sensitivity. IEEE Trans Med Imaging (1997) 0.97
Differences in reutilization of thymidine in hemopoietic and lymphopoietic tissues of the normal mouse. Cell Tissue Kinet (1973) 0.97
Syntactic processing in left prefrontal cortex is independent of lexical meaning. Neuroimage (2001) 0.97
Survival of patients with acute renal failure requiring dialysis after open heart surgery: early prognostic indicators. Am Heart J (1987) 0.96
Influence of age on pulmonary haemodynamics at rest and during supine exercise. Clin Sci (Lond) (1983) 0.96
Multiple Y receptors mediate pancreatic polypeptide responses in mouse colon mucosa. Peptides (2001) 0.96
Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience (2008) 0.95
Biological damage from the Auger effect, possible benefits. Radiat Environ Biophys (1975) 0.95
Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion. Int J Obes (Lond) (2009) 0.95
The role of ventral medial wall motor areas in bimanual co-ordination. A combined lesion and activation study. Brain (1999) 0.94
Large-scale plasticity of the human motor cortex. Neuroreport (1995) 0.94
Precentral glioma location determines the displacement of cortical hand representation. Neurosurgery (1998) 0.94
Conscious and subconscious sensorimotor synchronization--prefrontal cortex and the influence of awareness. Neuroimage (2002) 0.93
Cellular and nuclear volume of human cells during the cell cycle. Radiat Environ Biophys (1981) 0.93
Evoked potentials in patients with Huntington's disease and their offspring. I. Somatosensory evoked potentials. Electroencephalogr Clin Neurophysiol (1984) 0.93
Proliferation kinetics of early hemopoietic precursor cells with self sustaining capacity in the mouse, studied with 125-I-labeled iodo-deoxyuridine. Exp Hematol (1979) 0.92
Isolation of a cDNA clone for human NAD+: protein ADP-ribosyltransferase. Eur J Cell Biol (1987) 0.92
Y-receptor-like genes GPR72 and GPR73: molecular cloning, genomic organisation and assignment to human chromosome 11q21.1 and 2p14 and mouse chromosome 9 and 6. Biochim Biophys Acta (2000) 0.92
Notions about human stem cells. Nouv Rev Fr Hematol Blood Cells (1976) 0.92
Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study. Clin Endocrinol (Oxf) (1999) 0.92
3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. J Nucl Med (1997) 0.92
Spinal abscess and bacterial meningitis in Crohn's disease. Dig Dis Sci (1992) 0.91
Molecular biology, epidemiology, and the demise of the linear no-threshold (LNT) hypothesis. C R Acad Sci III (1999) 0.91
Meningioangiomatosis in a patient with progressive focal neurological deficit-case report and review of literature. Br J Neurosurg (2012) 0.91
What is a 'low dose' of radiation? Int J Radiat Biol Relat Stud Phys Chem Med (1988) 0.90
An assay for the measurement of residual damage of murine hematopoietic stem cells. Exp Hematol (1981) 0.90
The superiority of combined continuous wave Doppler examination over periorbital Doppler for the detection of extracranial carotid disease. J Neurol Neurosurg Psychiatry (1984) 0.89
Local inflammation and devascularization--in vivo mechanisms of the "bystander effect" in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma. Cancer Gene Ther (2001) 0.89